Bristol-Myers Squibb Beats Earnings Estimates and More - Presented by: The Aol. On Network

Bristol-Myers Squibb reported higher than expected quarterly earnings on Tuesday, helped by cost cuts and lower taxes. There were concerns over a possible delay in completing its marketing application for a high-profile cancer drug. BMY posted Q1 earnings of 56 cents per share, beating estimates of 43 cents a share, while revenue dipped to $3.81 billion, missing estimates of $3.89 billion. Bristol-Myers Squibb also announced the acquisition of iPierian for $175 million.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 17.26 0.54 ▲ 3.23%
PBR/A $ 7.02 0.30 ▲ 4.46%
PBR $ 6.70 0.42 ▲ 6.69%
GE $ 24.66 0.17 ▲ 0.69%
QQQ $ 101.80 1.82 ▲ 1.82%
TLM $ 7.64 0.06 ▲ 0.79%
VOLC $ 17.84 6.35 ▲ 55.27%
MGM $ 18.01 0.84 ▼ 4.46%

As of 12/17/2014, 04:15 PM
More Most Active